Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Systemic Mastocytosis
Related studies linked through entity extraction aliases.
Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis
- Status
- RECRUITING
- Phase
- N/A
Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis
- Status
- COMPLETED
- Phase
- PHASE3
GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Treatment of Indolent Systemic Mastocytosis With PA101
- Status
- COMPLETED
- Phase
- PHASE2
Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis
- Status
- COMPLETED
- Phase
- NA
Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis
- Status
- TERMINATED
- Phase
- PHASE2
Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Use of Tamoxifen in Systemic Mastocytosis
- Status
- COMPLETED
- Phase
- N/A
Imatinib in KIT-negative Systemic Mastocytosis
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of Response of Dasatinib to Treat Mastocytosis
- Status
- UNKNOWN
- Phase
- PHASE2
Obatoclax for Systemic Mastocytosis
- Status
- TERMINATED
- Phase
- PHASE2
Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
- Status
- COMPLETED
- Phase
- PHASE2
Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2